Meaningful Ways to Support CISCRP This Holiday Season
November 2, 2015
Second Annual SCRS Run for the Heroes Supports CISCRP’s Educational Initiatives
November 2, 2015
Show all

CISCRP Unveils the Results of the 2015 Perceptions & Insights Study

This Fall CISCRP will unveil the results of the 2015 global Public and Patient Perceptions & Insights study beginning with a webinar in late October followed by conference presentations and onsite company meetings.

The webinar on October 28 posed a unique opportunity for professionals from all over to tune in and hear directly from CISCRP Founder and Board Chair, Ken Getz and key leadership staff. CISCRP shared the recent study findings around public and patient perceptions, attitudes, and experiences in regards to clinical research, as well as the meanings and implications associated with these results.

With more than 12,000 respondents, the 2015 CISCRP Perceptions & Insights study is the largest global survey of its kind. The large response base allows CISCRP to conduct in-depth subgroup analyses by a variety of demographic and attitudinal variables including age, race & ethnicity, socio-economic status, disease condition, and global region.

In late 2015 and into 2016, CISCRP will be publishing the results of the study in special reports, peer-review journals and trade-press articles.

The 2015 Perceptions & Insights study offers invaluable insights for clinical research professionals — sponsor Perceptions & Insights_2.19.15 018_2companies, CROs, investigative sites, and other stakeholders – looking to more effectively engage their study participants as partners in the clinical research process.

Later this year and throughout 2016, based on a generous educational grant from Acurian, CISCRP will be holding onsite company ‘Roundtables’ to present and discuss the results of the 2015 Perceptions & Insights study.  As part of these programs, CISCRP will facilitate a discussion to generate concrete action steps.  Roundtable meetings are already scheduled at AbbVie, Boehringer-Ingelheim, Astellas and Takeda.

If you’re interested in learning more about the opportunity to host an exclusive roundtable discussion of the study results and their implication at your company, please contact Ellyn Getz at

Read the next article >>

Comments are closed.